The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
WHO has prequalified two rapid COVID-19 antigen tests, confirming their safety and quality and expanding access to fast, ...
This study systematically elucidates the drug resistance mechanisms of five highly pathogenic viruses, proposes five innovative anti-resistance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback